Vice President & Global Head, Oncology Communications & Advocacy, Novartis Oncology
At Novartis Oncology, we work hard to develop innovative treatments, and we also believe it’s important to connect with the cancer community on a more personal level; this includes patients, families, caregivers, advocates and physicians. While we have connected with many of these stakeholders and we can’t talk to everyone in person, we think a great way to deepen our connection is through social media, using platforms that allow us to have a two-way dialogue. That’s why we’re excited to announce the start of the new @NovartisCancer Twitter handle. Our hope is to better engage directly with the cancer community by providing information and resources for various audiences, including the patients who follow us.
On @NovartisCancer we will be sharing updates on clinical trial data and other treatment milestones like approvals, meaningful disease awareness initiatives, and patient resources such as tips, fact sheets, information on patient assistance programs and more.
We encourage you to follow us, share your stories, and provide us with feedback.